- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
According to our latest study, the global Gabapentin market size was valued at USD 1586.6 million in 2022 and is forecast to a readjusted size of USD 1788.1 million by 2029 with a CAGR of 1.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Gabapentin key players include Novartis, TEVA, Mylan, Pfizer, etc. Global top four manufacturers hold a share about 20%.
North America is the largest market, with a share over 30%, followed by Asia-Pacific, and Europe, both have a share about 50 percent.
In terms of product, Capsule is the largest segment, with a share about 55%. And in terms of application, the largest application is Epilepsy, followed by Neuropathic Pain, Restless Legs Syndrome, etc.
This report is a detailed and comprehensive analysis for global Gabapentin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Gabapentin market size and forecasts, in consumption value ($ Million), sales quantity (M Unit), and average selling prices (USD/Unit), 2018-2029
Global Gabapentin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Unit), and average selling prices (USD/Unit), 2018-2029
Global Gabapentin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Unit), and average selling prices (USD/Unit), 2018-2029
Global Gabapentin market shares of main players, shipments in revenue ($ Million), sales quantity (M Unit), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gabapentin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gabapentin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Assertio Therapeutics, TEVA, Mylan and Arbor Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Gabapentin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Capsule
Tablet
Market segment by Application
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
Major players covered
Pfizer
Assertio Therapeutics
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gabapentin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gabapentin, with price, sales, revenue and global market share of Gabapentin from 2018 to 2023.
Chapter 3, the Gabapentin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gabapentin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Gabapentin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gabapentin.
Chapter 14 and 15, to describe Gabapentin sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Gabapentin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Gabapentin Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Capsule
1.3.3 Tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Gabapentin Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Epilepsy
1.4.3 Neuropathic Pain
1.4.4 Restless Legs Syndrome
1.4.5 Others
1.5 Global Gabapentin Market Size & Forecast
1.5.1 Global Gabapentin Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Gabapentin Sales Quantity (2018-2029)
1.5.3 Global Gabapentin Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Gabapentin Product and Services
2.1.4 Pfizer Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Assertio Therapeutics
2.2.1 Assertio Therapeutics Details
2.2.2 Assertio Therapeutics Major Business
2.2.3 Assertio Therapeutics Gabapentin Product and Services
2.2.4 Assertio Therapeutics Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Assertio Therapeutics Recent Developments/Updates
2.3 TEVA
2.3.1 TEVA Details
2.3.2 TEVA Major Business
2.3.3 TEVA Gabapentin Product and Services
2.3.4 TEVA Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 TEVA Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Gabapentin Product and Services
2.4.4 Mylan Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mylan Recent Developments/Updates
2.5 Arbor Pharma
2.5.1 Arbor Pharma Details
2.5.2 Arbor Pharma Major Business
2.5.3 Arbor Pharma Gabapentin Product and Services
2.5.4 Arbor Pharma Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Arbor Pharma Recent Developments/Updates
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Gabapentin Product and Services
2.6.4 Novartis Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Recent Developments/Updates
2.7 Apotex
2.7.1 Apotex Details
2.7.2 Apotex Major Business
2.7.3 Apotex Gabapentin Product and Services
2.7.4 Apotex Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Apotex Recent Developments/Updates
2.8 Sun Pharmaceutical
2.8.1 Sun Pharmaceutical Details
2.8.2 Sun Pharmaceutical Major Business
2.8.3 Sun Pharmaceutical Gabapentin Product and Services
2.8.4 Sun Pharmaceutical Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sun Pharmaceutical Recent Developments/Updates
2.9 Aurobindo Pharma
2.9.1 Aurobindo Pharma Details
2.9.2 Aurobindo Pharma Major Business
2.9.3 Aurobindo Pharma Gabapentin Product and Services
2.9.4 Aurobindo Pharma Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aurobindo Pharma Recent Developments/Updates
2.10 Intas
2.10.1 Intas Details
2.10.2 Intas Major Business
2.10.3 Intas Gabapentin Product and Services
2.10.4 Intas Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Intas Recent Developments/Updates
2.11 Amneal
2.11.1 Amneal Details
2.11.2 Amneal Major Business
2.11.3 Amneal Gabapentin Product and Services
2.11.4 Amneal Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Amneal Recent Developments/Updates
2.12 Marksans Pharma
2.12.1 Marksans Pharma Details
2.12.2 Marksans Pharma Major Business
2.12.3 Marksans Pharma Gabapentin Product and Services
2.12.4 Marksans Pharma Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Marksans Pharma Recent Developments/Updates
2.13 Glenmark
2.13.1 Glenmark Details
2.13.2 Glenmark Major Business
2.13.3 Glenmark Gabapentin Product and Services
2.13.4 Glenmark Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Glenmark Recent Developments/Updates
2.14 Alkem
2.14.1 Alkem Details
2.14.2 Alkem Major Business
2.14.3 Alkem Gabapentin Product and Services
2.14.4 Alkem Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Alkem Recent Developments/Updates
2.15 Jiangsu Enhua
2.15.1 Jiangsu Enhua Details
2.15.2 Jiangsu Enhua Major Business
2.15.3 Jiangsu Enhua Gabapentin Product and Services
2.15.4 Jiangsu Enhua Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Jiangsu Enhua Recent Developments/Updates
2.16 Jiangsu Hengrui
2.16.1 Jiangsu Hengrui Details
2.16.2 Jiangsu Hengrui Major Business
2.16.3 Jiangsu Hengrui Gabapentin Product and Services
2.16.4 Jiangsu Hengrui Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Jiangsu Hengrui Recent Developments/Updates
2.17 Sailike
2.17.1 Sailike Details
2.17.2 Sailike Major Business
2.17.3 Sailike Gabapentin Product and Services
2.17.4 Sailike Gabapentin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Sailike Recent Developments/Updates
3 Competitive Environment: Gabapentin by Manufacturer
3.1 Global Gabapentin Sales Quantity by Manufacturer (2018-2023)
3.2 Global Gabapentin Revenue by Manufacturer (2018-2023)
3.3 Global Gabapentin Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Gabapentin by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Gabapentin Manufacturer Market Share in 2022
3.4.2 Top 6 Gabapentin Manufacturer Market Share in 2022
3.5 Gabapentin Market: Overall Company Footprint Analysis
3.5.1 Gabapentin Market: Region Footprint
3.5.2 Gabapentin Market: Company Product Type Footprint
3.5.3 Gabapentin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Gabapentin Market Size by Region
4.1.1 Global Gabapentin Sales Quantity by Region (2018-2029)
4.1.2 Global Gabapentin Consumption Value by Region (2018-2029)
4.1.3 Global Gabapentin Average Price by Region (2018-2029)
4.2 North America Gabapentin Consumption Value (2018-2029)
4.3 Europe Gabapentin Consumption Value (2018-2029)
4.4 Asia-Pacific Gabapentin Consumption Value (2018-2029)
4.5 South America Gabapentin Consumption Value (2018-2029)
4.6 Middle East and Africa Gabapentin Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Gabapentin Sales Quantity by Type (2018-2029)
5.2 Global Gabapentin Consumption Value by Type (2018-2029)
5.3 Global Gabapentin Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Gabapentin Sales Quantity by Application (2018-2029)
6.2 Global Gabapentin Consumption Value by Application (2018-2029)
6.3 Global Gabapentin Average Price by Application (2018-2029)
7 North America
7.1 North America Gabapentin Sales Quantity by Type (2018-2029)
7.2 North America Gabapentin Sales Quantity by Application (2018-2029)
7.3 North America Gabapentin Market Size by Country
7.3.1 North America Gabapentin Sales Quantity by Country (2018-2029)
7.3.2 North America Gabapentin Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Gabapentin Sales Quantity by Type (2018-2029)
8.2 Europe Gabapentin Sales Quantity by Application (2018-2029)
8.3 Europe Gabapentin Market Size by Country
8.3.1 Europe Gabapentin Sales Quantity by Country (2018-2029)
8.3.2 Europe Gabapentin Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Gabapentin Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Gabapentin Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Gabapentin Market Size by Region
9.3.1 Asia-Pacific Gabapentin Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Gabapentin Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Gabapentin Sales Quantity by Type (2018-2029)
10.2 South America Gabapentin Sales Quantity by Application (2018-2029)
10.3 South America Gabapentin Market Size by Country
10.3.1 South America Gabapentin Sales Quantity by Country (2018-2029)
10.3.2 South America Gabapentin Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Gabapentin Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Gabapentin Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Gabapentin Market Size by Country
11.3.1 Middle East & Africa Gabapentin Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Gabapentin Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Gabapentin Market Drivers
12.2 Gabapentin Market Restraints
12.3 Gabapentin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Gabapentin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Gabapentin
13.3 Gabapentin Production Process
13.4 Gabapentin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Gabapentin Typical Distributors
14.3 Gabapentin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Gabapentin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Gabapentin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Gabapentin Product and Services
Table 6. Pfizer Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Assertio Therapeutics Basic Information, Manufacturing Base and Competitors
Table 9. Assertio Therapeutics Major Business
Table 10. Assertio Therapeutics Gabapentin Product and Services
Table 11. Assertio Therapeutics Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Assertio Therapeutics Recent Developments/Updates
Table 13. TEVA Basic Information, Manufacturing Base and Competitors
Table 14. TEVA Major Business
Table 15. TEVA Gabapentin Product and Services
Table 16. TEVA Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. TEVA Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Gabapentin Product and Services
Table 21. Mylan Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mylan Recent Developments/Updates
Table 23. Arbor Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Arbor Pharma Major Business
Table 25. Arbor Pharma Gabapentin Product and Services
Table 26. Arbor Pharma Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Arbor Pharma Recent Developments/Updates
Table 28. Novartis Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Major Business
Table 30. Novartis Gabapentin Product and Services
Table 31. Novartis Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novartis Recent Developments/Updates
Table 33. Apotex Basic Information, Manufacturing Base and Competitors
Table 34. Apotex Major Business
Table 35. Apotex Gabapentin Product and Services
Table 36. Apotex Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Apotex Recent Developments/Updates
Table 38. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Sun Pharmaceutical Major Business
Table 40. Sun Pharmaceutical Gabapentin Product and Services
Table 41. Sun Pharmaceutical Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sun Pharmaceutical Recent Developments/Updates
Table 43. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Aurobindo Pharma Major Business
Table 45. Aurobindo Pharma Gabapentin Product and Services
Table 46. Aurobindo Pharma Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Aurobindo Pharma Recent Developments/Updates
Table 48. Intas Basic Information, Manufacturing Base and Competitors
Table 49. Intas Major Business
Table 50. Intas Gabapentin Product and Services
Table 51. Intas Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Intas Recent Developments/Updates
Table 53. Amneal Basic Information, Manufacturing Base and Competitors
Table 54. Amneal Major Business
Table 55. Amneal Gabapentin Product and Services
Table 56. Amneal Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Amneal Recent Developments/Updates
Table 58. Marksans Pharma Basic Information, Manufacturing Base and Competitors
Table 59. Marksans Pharma Major Business
Table 60. Marksans Pharma Gabapentin Product and Services
Table 61. Marksans Pharma Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Marksans Pharma Recent Developments/Updates
Table 63. Glenmark Basic Information, Manufacturing Base and Competitors
Table 64. Glenmark Major Business
Table 65. Glenmark Gabapentin Product and Services
Table 66. Glenmark Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Glenmark Recent Developments/Updates
Table 68. Alkem Basic Information, Manufacturing Base and Competitors
Table 69. Alkem Major Business
Table 70. Alkem Gabapentin Product and Services
Table 71. Alkem Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Alkem Recent Developments/Updates
Table 73. Jiangsu Enhua Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Enhua Major Business
Table 75. Jiangsu Enhua Gabapentin Product and Services
Table 76. Jiangsu Enhua Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jiangsu Enhua Recent Developments/Updates
Table 78. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 79. Jiangsu Hengrui Major Business
Table 80. Jiangsu Hengrui Gabapentin Product and Services
Table 81. Jiangsu Hengrui Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Jiangsu Hengrui Recent Developments/Updates
Table 83. Sailike Basic Information, Manufacturing Base and Competitors
Table 84. Sailike Major Business
Table 85. Sailike Gabapentin Product and Services
Table 86. Sailike Gabapentin Sales Quantity (M Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Sailike Recent Developments/Updates
Table 88. Global Gabapentin Sales Quantity by Manufacturer (2018-2023) & (M Unit)
Table 89. Global Gabapentin Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Gabapentin Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 91. Market Position of Manufacturers in Gabapentin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Gabapentin Production Site of Key Manufacturer
Table 93. Gabapentin Market: Company Product Type Footprint
Table 94. Gabapentin Market: Company Product Application Footprint
Table 95. Gabapentin New Market Entrants and Barriers to Market Entry
Table 96. Gabapentin Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Gabapentin Sales Quantity by Region (2018-2023) & (M Unit)
Table 98. Global Gabapentin Sales Quantity by Region (2024-2029) & (M Unit)
Table 99. Global Gabapentin Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Gabapentin Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Gabapentin Average Price by Region (2018-2023) & (USD/Unit)
Table 102. Global Gabapentin Average Price by Region (2024-2029) & (USD/Unit)
Table 103. Global Gabapentin Sales Quantity by Type (2018-2023) & (M Unit)
Table 104. Global Gabapentin Sales Quantity by Type (2024-2029) & (M Unit)
Table 105. Global Gabapentin Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Gabapentin Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Gabapentin Average Price by Type (2018-2023) & (USD/Unit)
Table 108. Global Gabapentin Average Price by Type (2024-2029) & (USD/Unit)
Table 109. Global Gabapentin Sales Quantity by Application (2018-2023) & (M Unit)
Table 110. Global Gabapentin Sales Quantity by Application (2024-2029) & (M Unit)
Table 111. Global Gabapentin Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Gabapentin Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Gabapentin Average Price by Application (2018-2023) & (USD/Unit)
Table 114. Global Gabapentin Average Price by Application (2024-2029) & (USD/Unit)
Table 115. North America Gabapentin Sales Quantity by Type (2018-2023) & (M Unit)
Table 116. North America Gabapentin Sales Quantity by Type (2024-2029) & (M Unit)
Table 117. North America Gabapentin Sales Quantity by Application (2018-2023) & (M Unit)
Table 118. North America Gabapentin Sales Quantity by Application (2024-2029) & (M Unit)
Table 119. North America Gabapentin Sales Quantity by Country (2018-2023) & (M Unit)
Table 120. North America Gabapentin Sales Quantity by Country (2024-2029) & (M Unit)
Table 121. North America Gabapentin Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Gabapentin Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Gabapentin Sales Quantity by Type (2018-2023) & (M Unit)
Table 124. Europe Gabapentin Sales Quantity by Type (2024-2029) & (M Unit)
Table 125. Europe Gabapentin Sales Quantity by Application (2018-2023) & (M Unit)
Table 126. Europe Gabapentin Sales Quantity by Application (2024-2029) & (M Unit)
Table 127. Europe Gabapentin Sales Quantity by Country (2018-2023) & (M Unit)
Table 128. Europe Gabapentin Sales Quantity by Country (2024-2029) & (M Unit)
Table 129. Europe Gabapentin Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Gabapentin Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Gabapentin Sales Quantity by Type (2018-2023) & (M Unit)
Table 132. Asia-Pacific Gabapentin Sales Quantity by Type (2024-2029) & (M Unit)
Table 133. Asia-Pacific Gabapentin Sales Quantity by Application (2018-2023) & (M Unit)
Table 134. Asia-Pacific Gabapentin Sales Quantity by Application (2024-2029) & (M Unit)
Table 135. Asia-Pacific Gabapentin Sales Quantity by Region (2018-2023) & (M Unit)
Table 136. Asia-Pacific Gabapentin Sales Quantity by Region (2024-2029) & (M Unit)
Table 137. Asia-Pacific Gabapentin Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Gabapentin Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Gabapentin Sales Quantity by Type (2018-2023) & (M Unit)
Table 140. South America Gabapentin Sales Quantity by Type (2024-2029) & (M Unit)
Table 141. South America Gabapentin Sales Quantity by Application (2018-2023) & (M Unit)
Table 142. South America Gabapentin Sales Quantity by Application (2024-2029) & (M Unit)
Table 143. South America Gabapentin Sales Quantity by Country (2018-2023) & (M Unit)
Table 144. South America Gabapentin Sales Quantity by Country (2024-2029) & (M Unit)
Table 145. South America Gabapentin Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Gabapentin Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Gabapentin Sales Quantity by Type (2018-2023) & (M Unit)
Table 148. Middle East & Africa Gabapentin Sales Quantity by Type (2024-2029) & (M Unit)
Table 149. Middle East & Africa Gabapentin Sales Quantity by Application (2018-2023) & (M Unit)
Table 150. Middle East & Africa Gabapentin Sales Quantity by Application (2024-2029) & (M Unit)
Table 151. Middle East & Africa Gabapentin Sales Quantity by Region (2018-2023) & (M Unit)
Table 152. Middle East & Africa Gabapentin Sales Quantity by Region (2024-2029) & (M Unit)
Table 153. Middle East & Africa Gabapentin Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Gabapentin Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Gabapentin Raw Material
Table 156. Key Manufacturers of Gabapentin Raw Materials
Table 157. Gabapentin Typical Distributors
Table 158. Gabapentin Typical Customers
List of Figures
Figure 1. Gabapentin Picture
Figure 2. Global Gabapentin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Gabapentin Consumption Value Market Share by Type in 2022
Figure 4. Capsule Examples
Figure 5. Tablet Examples
Figure 6. Global Gabapentin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Gabapentin Consumption Value Market Share by Application in 2022
Figure 8. Epilepsy Examples
Figure 9. Neuropathic Pain Examples
Figure 10. Restless Legs Syndrome Examples
Figure 11. Others Examples
Figure 12. Global Gabapentin Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Gabapentin Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Gabapentin Sales Quantity (2018-2029) & (M Unit)
Figure 15. Global Gabapentin Average Price (2018-2029) & (USD/Unit)
Figure 16. Global Gabapentin Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Gabapentin Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Gabapentin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Gabapentin Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Gabapentin Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Gabapentin Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Gabapentin Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Gabapentin Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Gabapentin Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Gabapentin Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Gabapentin Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Gabapentin Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Gabapentin Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Gabapentin Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Gabapentin Average Price by Type (2018-2029) & (USD/Unit)
Figure 31. Global Gabapentin Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Gabapentin Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Gabapentin Average Price by Application (2018-2029) & (USD/Unit)
Figure 34. North America Gabapentin Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Gabapentin Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Gabapentin Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Gabapentin Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Gabapentin Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Gabapentin Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Gabapentin Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Gabapentin Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Gabapentin Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Gabapentin Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Gabapentin Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Gabapentin Consumption Value Market Share by Region (2018-2029)
Figure 54. China Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Gabapentin Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Gabapentin Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Gabapentin Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Gabapentin Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Gabapentin Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Gabapentin Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Gabapentin Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Gabapentin Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Gabapentin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Gabapentin Market Drivers
Figure 75. Gabapentin Market Restraints
Figure 76. Gabapentin Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Gabapentin in 2022
Figure 79. Manufacturing Process Analysis of Gabapentin
Figure 80. Gabapentin Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
